day 1 agenda
| Scientific Program | ||
| 7th Edition of International Vaccine Congress (IVC-2026) July 06-07, 2026 | Rome, Italy |
||
| Day-1 (July 06, 2026) | ||
| Meeting Hall - 1 | ||
| 08:30-09:00 | Registrations | |
| 09:00-09:30 | Welcome Remarks by Moderator | |
| Keynote Talks | ||
| Ted Rothstein, George Washington University, USA |
09:30-10:00 | Title:- Neuroanatomic changes associated with 55 consecutive long-term post COVID-19 patients with cognitive deficits |
| Bram Palache, Flupal Consultancy, Netherlands |
10:00-10:30 | Title:- Disparities in Seasonal Influenza Vaccination in Europe |
| Group Photo & Refreshment Break (10:30-10:50) | ||
| Technical Session-I | ||
| Session Chairs: TBA | ||
| Moriya Tsuji, Columbia University, USA |
10:50-11:10 | Title:- Harnessing CD1d-restricted NKT cells to prevent respiratory viral infections in vivo |
| Thomas P Monath, Quigley Biopharma, USA |
11:10-11:30 | Title:- PHV02 Live, attenuated recombinant VSV vaccine against Nipah Virus: Clinical trial update |
| Manish A Mahajan, Zydus Lifesciences, India |
11:30-11:50 | Title:- Adaptive Clinical Trial Designs in Lower Middle Income Countries: Role Beyond Pandemic Preparedness |
| Arlene Calvo, University of South Florida, USA |
11:50-12:10 | Title:- Follow-up of HPV Vaccine Outcomes in Panama |
| Jürgen Gailer, University of Calgaray, Canada |
12:10-12:30 | Title:- Degradation of the Vaccine Additive Thimerosal by L-Glutathione and L-Cysteine at Physiological pH |
| Rajendra Upadhya, Duke University, USA |
12:30-12:50 | Title:- Targeting Fungal Cell Wall Biology to Develop Whole-Cell Vaccines Against Cryptococcosis |
| Bella Manshion, KU Leuven, Belgium |
12:50-13:10 | Title:- Combination therapy of inorganic nanocparticles with Anti-PD1 reduces tumor growth and acts as targeted selective anti-tumor therapy |
| Lunch Break @ Restaurant (13:10-14:00) | ||
| Technical Session-II | ||
| Session Chairs: TBA | ||
| Rene Traksel, Maxima Medical Center, Netherlands |
14:00-14:20 | Title:- Oral iodine in COVID-19 patients: effects on clinical outcomes and antiviral immune responses |
| Adam Frederik Sander, University of Copenhagen, Denmark |
14:20-14:40 | Title:- Combining mRNA Speed with cVLP immunogenicity - A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles |
| Albert Jonathan Auguste, Virginia Tech, USA |
14:40-15:00 | Title:- Exploring the immunogenicity and efficacy of an insect virus-based vaccine against Zika virus and Spondweni virus |
| Ademola O. Olaniran, University of KwaZulu-Natal, South Africa |
15:00-15:20 | Title:- Rotaviruses in treated wastewater effluent and receiving aquatic milieu: Prevalence, Genetic characterization and Infectivity |
| Mya Myat Ngwe Tun, Nagasaki University, Japan |
15:20-15:40 | Title:- : A Multicounty assessment of Chikungunya Virus Infection in Asia Using Molecular and Serological Approaches |
| Maroua Kammoun, CER groupe, Belgium |
15:40-16:00 | Title:- : BLI as a rapid and label-free technology for characterizing biomolecular interactions in immunology |
| Refreshment Break (16:00-16:20) | ||
| Sara Al Dahir & Alaa Khalil, Xavier University of Louisiana, USA |
16:20-16:40 | Title:- : The Impact of Coronavirus Pandemic Shutdowns on Immunization Completion in Hadeetha, Anbar, Iraq: A Case-Study of Vaccine Completion in a Recovering Healthcare System |
| Raymond Kaempfer, Hebrew University of Jerusalem, Israel |
16:40-17:00 | Title:-Positive Regulation of Splicing of Cellular and Viral mRNA by Intragenic RNA Elements That Activate the Stress Kinase PKR, an Antiviral Mechanism |
| Beatriz López-Cauce, Worg Pharmaceuticals, Spain |
17:00-17:20 | Title:- Real World Safety and Effectiveness of High Dose Subcutaneous Immunotherapy with Glutaraldehyde Polymerized Allergen Extracts in Respiratory Allergy |
| Laura Ortega Martín, Worg Pharmaceuticals, Spain |
17:20-17:40 | Title:- Molecular Sensitization Patterns to Dust Mite Allergens in a Region of Galicia: A Serodominance Study in Lugo |
| Panel Discussions | ||
| NOTE: This is Tentative program and subject to change | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to: foodscience@innovinc.org | ||
day 2 agenda
| Day-2 (July 07, 2026) | ||
| Meeting Hall - 1 | ||
| 09:20-09:30 | Welcome Remarks by Moderator | |
| Keynote Talks | ||
| Airi Poder, Clinical Research OU, Estonia |
09:30-10:00 | Title:- Recruitment Strategies for Vaccine Trials in Areas of Low Population Density |
| Kai-Michael Toellner, Babraham Institue, UK, |
10:00-10:30 | Title:- Mastering Immunity: Antibody Feedback as a Driver of Germinal Centre Fate and Vaccine Responses |
| Technical Session-III | ||
| Session Chairs: TBA | ||
| Camilla Foged, University of Copenhagen, Denmark |
10:30-10:50 | Title:- Design of messenger RNA vaccines based on lipid-polymer hybrid nanoparticles |
| Sara Landeras, University CEU, Spain |
10:50-11:10 | Title:- Antigenic landscape and structural stabilization of the SARS-CoV-2 Nucleocapsid protein |
| Refreshment Break (11:10-11:30) | ||
| Andrea Malaspina, University College London, UK |
11:30-11:50 | Title:- Neurofilament and Dipeptide Repeats Autoantibodies and Loss of Immune Tolerance in Amyotrophic Lateral Sclerosis |
| Roberto Ademo, GlaxoSmithkile, Italy |
11:50-12:10 | Title:- Towards a polysaccharide-based Group B Streptococcus vaccinefor Global Health |
| Ying Peng, Zhengzhou University, China |
12:10-12:30 | Title:- A cDC1 targeting, plug-and-play custom nanoparticle vaccine triggers effective cancer immunity |
| Gertrude Nakigozi, SDSU, USA |
12:30-12:50 | Title:- Preparing for Expanded Maternal Immunization: Healthcare Provider Perspectives on Barriers to Vaccine Uptake in Uganda |
| Ximeng Han, University of Oxford, UK |
12:50-13:10 | Title:- Preclinical Development of an Enhanced-Immunogenicity Malaria Transmission-Blocking Vaccine |
| Lunch Break @ Restaurant (13:10-14:00) | ||
| Technical Session- IV (14:00-15:00) - Poster Viewing | ||
| Technical Session- V | ||
| Session Chairs: TBA | ||
| Stine Søgaard Normann, University of Southern Denmark, Copenhagen |
15:00-15:20 | Title:- Prenatal and childhood PFAS exposure and vaccine?induced immunity at 15 years of age in a Faroe mother?child cohort |
| Sam Pallerla, IAVI, USA |
15:20-15:40 | Title:- Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoparticles (SMNP) |
| Mouhamed Kane, Institut Pasteur de Daka, Senegal |
15:40-16:00 | Title:- Evaluating Myxovirus Resistance Protein A-Based Rapid Testing Combined with Pathogen Sequencing for Arboviral and Incidental Viral Infection Surveillance in Senegal |
| Daniel Knott, UKHSA, UK |
16:00-16:20 | Title:- From development to deployment: transferring SARS CoV 2 neutralisation assays across a global laboratory network |
| Refreshment Break (16:20-16:40) | ||
| Clint McDaniel, UMass Chan, USA |
16:40-17:00 | Title:- Cryo-electron tomography reveals virion-associated influenza hemagglutinin clusters upon receptor binding |
| Antonio Acosta-Hoyos, Universidad Simón Bolívar, Columbia |
17:00-17:20 | Title:- Point-of-care dengue screening and viremia stratification by raman spectroscopy of serum liquid biopsies |
| Panel Discussions | ||
| NOTE: This is Tentative program and subject to change | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to: foodscience@innovinc.org | ||
posters agenda
| Poster Presentations | ||
| Day-2 (July 07, 2026) | ||
| Technical Session- IV (14:00-15:00) - Poster Viewing | ||
| Gulgul Kairanbayeva, Asfendiyarov Kazakh National Medical University, Kazakhstan |
P-1 | Title:- Artificial Intelligence-Assisted PASI Scoring in Experimental Psoriasis: comparison with Classical Method |
| Marina Balabekova, Asfendiyarov Kazakh National Medical University, Kazakhstan |
P-2 | Title:- Phosphorodiamidate Morpholino Oligomers Demonstrate Pronounced Anti-Inflammatory Activity in Experimental Psoriasis |
| Diana Luisa Campos Ferreira Ramos, University of Porto, Portugal |
P-3 | Title:- Identification of mosquito antigens using reverse vaccinology to design a vaccine candidate against multiple flaviviruses |
| Elchin Huseynov, Azerbaijan Medical University, Azerbaijan |
P-4 | Title:- The Features Of Acute Brucellosis In Azerbaijan Republic |
| Gertrude Nakigozi, SDSU, USA |
P-5 | Title:- Complacency and convenience remain linked despite high vaccine confidence: attitudes among pregnant individuals, those planning pregnancy, and partners in Uganda |
| Anderson Pereira Soares, University of Campinas, Brazil |
P-6 | Title:- B-cell epitope mapping of Orthoflavivirus zikaense in mother-newborn immune interaction reveals postnatal immune signatures |
| Panel Discussions | ||
| NOTE: This is Tentative program and subject to change | ||
| If any one interested to attend the conference or to book your poster slot, please send an email to: foodscience@innovinc.org | ||
posters agenda
Will be updated soon...